Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Sponsorship: Partisan Bill (Democrat 1)

Status: (Introduced - Dead) 2024-02-12 - Introduced, Referred to Assembly Health Committee [A3621 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2024-02-13	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New Jersey A3621

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New Jersey A3621 currently on file.